trans-o-flex ThermoMed, the specialist for the actively temperature-controlled transportation of pharmaceuticals within the range of 2 to 8 °C, is going to replace a large part of its transport fleet. The company has ordered a total of 165 new delivery vehicles, all of which will be delivered by the end of this year. The first vehicles have already been in operation since the middle of June. “With the purchase of the new vehicles, we take another step towards increasing our reliability, efficiency and eco-friendliness”, says Wolfgang P. Albeck, CEO of trans-o-flex.
In order to reach these goals, trans-o-flex ThermoMed decided to purchase three different types of vehicles, which will be deployed depending on the tours’ requirement profiles. The order includes 46 VW T6 Transporters and 46 Mercedes-Benz Vito vans as well as 73 Mercedes Sprinters with box bodies. All of the vehicles have been awarded a pharma certificate and meet the Euro 6 standard. They consume less diesel than their predecessors and their engines are cleaner. Nitric oxide (NOx) emissions, for instance, are more than 50 % lower (from 0.18 to 0.08 g/km). In addition to this, the vehicles have also been awarded an ATP certificate (for the FRCX category). Thus, with respect to the insulation of the loading space and the performance of the temperature control unit, the vehicles meet the highest international standards for refrigerated vehicles.
“This new investment of several millions of euros is part of the continuous modernisation and expansion of our entire transport fleet“, explains Albeck. Just a few weeks ago, at the beginning of June, trans-o-flex announced to purchase 81 new pharma-certified refrigerated trailers.
In order to reach these goals, trans-o-flex ThermoMed decided to purchase three different types of vehicles, which will be deployed depending on the tours’ requirement profiles. The order includes 46 VW T6 Transporters and 46 Mercedes-Benz Vito vans as well as 73 Mercedes Sprinters with box bodies. All of the vehicles have been awarded a pharma certificate and meet the Euro 6 standard. They consume less diesel than their predecessors and their engines are cleaner. Nitric oxide (NOx) emissions, for instance, are more than 50 % lower (from 0.18 to 0.08 g/km). In addition to this, the vehicles have also been awarded an ATP certificate (for the FRCX category). Thus, with respect to the insulation of the loading space and the performance of the temperature control unit, the vehicles meet the highest international standards for refrigerated vehicles.
“This new investment of several millions of euros is part of the continuous modernisation and expansion of our entire transport fleet“, explains Albeck. Just a few weeks ago, at the beginning of June, trans-o-flex announced to purchase 81 new pharma-certified refrigerated trailers.
